Whitney Kauffman, PA
Medical · Champaign, ILNPI 1043593262
Payments from drug & device makers
Across 32 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$140
- Lilly USA, LLC$51
- Biohaven Pharmaceuticals, Inc.$50
- Sunovion Pharmaceuticals Inc.$33
- Novartis$30
- Pfizer$30
- plus $152 from 8 others
What the payments were for
- Food & beverage$486100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $140 |
| Lilly USA, LLC | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Novartis | 2 | $30 |
| Pfizer | 1 | $30 |
| Organogenesis Inc. | 1 | $30 |
| Amgen | 1 | $26 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| AbbVie | 1 | $15 |
How this compares
$486 in reported general payments places this provider in the 50th percentile of 449 medical providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 27 | $6,023 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,593 |
| Rosuvastatin Calcium | 22 | $1,458 |
| Memantine Hcl | 12 | $1,278 |
| Gabapentin | 37 | $801 |
| Atorvastatin Calcium | 27 | $681 |
| Potassium Chloride | 22 | $603 |
| Mirtazapine | 23 | $565 |
| Baclofen | 11 | $499 |
| Metoprolol Succinate | 37 | $484 |
| Sertraline Hcl | 38 | $429 |
| Torsemide | 12 | $408 |
| Pantoprazole Sodium | 16 | $379 |
| Tramadol Hcl | 30 | $370 |
| Levothyroxine Sodium | 20 | $330 |
Paid to pharmacies, not to this prescriber.
Other medical in Champaign
- Warren LeeChampaign$11K
- Janice JonesChampaign$4K
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.